Navigation Links
Quorum Review IRB Appoints Michael Malafronte Director of Quality and Document Administration
Date:8/18/2008

Quorum Review IRB, an AAHRPP accredited ethics review board, today announced that they have appointed Michael Malafronte to the position of Director of Quality and Document Administration. Mr. Malafronte brings to Quorum 24 years of executive experience with quality systems and operations within the pharmaceutical industry. In his position Michael will lead Quorum in continuous quality improvement.

Seattle, WA (PRWEB) August 18, 2008 -- Quorum Review IRB, an AAHRPP accredited ethics review board, today announced that they have appointed Michael Malafronte to the position of Director of Quality and Document Administration. Mr. Malafronte brings to Quorum 24 years of executive experience with quality systems and operations within the pharmaceutical industry. In his position Michael will lead Quorum in continuous quality improvement.

As the demand for increased speed in human clinical trial review, document production and delivery continues, Quorum recognizes the importance of maintaining, implementing and improving robust quality systems. Mr. Malafronte brings with him a wealth of knowledge and experience to help Quorum build upon its market leading innovations while maintaining strict adherence to outstanding regulatory compliance practices. "Mike brings to Quorum the expertise to insure that Quorum's performance remains consistent, reliable and on the cutting edge," explains Cami Gearhart, CEO.

Prior to joining Quorum Review IRB, Mr. Malafronte directed quality groups at Nastech Pharmaceuticals, ICOS Corporation, and Abbott Labs. "It is a pleasure to be heading up the Quality Management and Document Administration teams at Quorum Review," says Mr. Malafronte. "I'm very excited about the on-going work here at Quorum and the outstanding groups that I will direct. My experience managing other quality organizations in the pharmaceutical business provides me with the background necessary to meet our quality goals and deliver documents to our customers in a timely manner."

About Quorum Review
Quorum Review is an independent ethics review board that is fully accredited by the Association for the Accreditation of Human Research Protection Programs (AAHRPP) and has been providing ethics review of drug and device trials since 1992. Quorum oversees research in accordance with U.S. and Canadian human research subject protection regulations, guidelines set forth by the International Committee on Harmonisation (ICH), and principles of the Belmont Report.    

Quorum's best-in-class service and support includes 3 protocol board meetings a week, daily amendment board meetings, 24 hour site review, 36 hour amendment review, and a secure web portal for online submissions, downloads and submission status review. Quorum can review studies in the US and Canada, review federally funded studies and has a specially designated Phase I study management team.

For information about Quorum Review services:
customerrelations@quorumreview.com
www.quorumreview.com

###

Read the full story at http://www.prweb.com/releases/institutional_review/independent_board/prweb1217544.htm


'/>"/>
Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved  

Related medicine news :

1. SEIU Sending Team to Review Finances at Local 6434, United Long Term Care Workers Union
2. Novel Diagnostic Marker for Acute Kidney Injury Previewed at Abbott-Sponsored Scientific Workshop
3. Combined Insurance Reports that Single Working Women's Week is a Good Time for Annual Review of Insurance Coverage
4. CVT Announces That FDA Continues to Review Ranexa(R) Applications
5. Abbott to Preview New CELL-DYN(R) Emerald(TM) Hematology Instrument
6. Rising Medical Solutions, Inc. Expands Its California Managed Care Services to Include Utilization Review Program
7. ACS Bowers Certified to Provide Utilization Review for State Medicaid Agencies
8. Pediatrics review of underage drinking prevention programs led by Iowa State researcher
9. LCA-Vision Provides Business Update and Market Review
10. 2008 Mitchell Medical Industry Conference Previews 100 Percent Paperless Auto Medical Claim Solution
11. American Scientific Resources, Inc. Discloses Reviewed Financials
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Quorum Review IRB Appoints Michael Malafronte Director of Quality and Document Administration
(Date:6/26/2016)... ... June 27, 2016 , ... Quality metrics are proliferating in ... ways they remain in the eye of the beholder, according to experts who offered ... The American Journal of Managed Care. For the full issue, click here . ...
(Date:6/26/2016)... Orion, Clarkston, Michigan (PRWEB) , ... June 26, ... ... with respect to fertility once they have been diagnosed with endometriosis. These women ... intercourse but they also require a comprehensive approach that can help for preservation ...
(Date:6/25/2016)... , ... June 25, 2016 , ... First Choice ... States, named Dr. Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm ... Medical Director of our new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical ...
(Date:6/24/2016)... ... 24, 2016 , ... A recent article published June 14 on ... article goes on to state that individuals are now more comfortable seeking to undergo ... such as calf and cheek reduction. The Los Angeles area medical group, Beverly Hills ...
(Date:6/24/2016)... ... June 24, 2016 , ... Global law firm Greenberg Traurig, ... Elite. The attorneys chosen by their peers for this recognition are considered among the ... Traurig Shareholders received special honors as members of this year’s Legal Elite Hall of ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... June 24, 2016 According to ... Type (Standard Pen Needles, Safety Pen Needles), Needle Length ... Growth Hormone), Mode of Purchase (Retail, Non-Retail) - Trends ... report studies the market for the forecast period of ... USD 2.81 Billion by 2021 from USD 1.65 Billion ...
(Date:6/24/2016)... June 24, 2016  Arkis BioSciences, a leading ... and more durable cerebrospinal fluid treatments, today announced ... Series-A funding is led by Innova Memphis, followed ... other private investors.  Arkis, new financing will accelerate ... the market release of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... , June 23, 2016 Any dentist who has ... of the current process. Many of them do not even ... technical difficulties and high laboratory costs involved. And those who ... it at such a high cost that the majority of ... Dr. Parsa Zadeh , founder of Dental Evolutions ...
Breaking Medicine Technology: